Macular Hole Following Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage Secondary to Neovascular AMD

Ophthalmic Surg Lasers Imaging Retina. 2019 Sep 1;50(9):e257-e259. doi: 10.3928/23258160-20190905-18.

Abstract

A full-thickness macular hole (FTMH) is a rare sequela to submacular hemorrhage. Herein, the authors report a case of an 80-year-old man actively being treated for neovascular age-related macular degeneration who presented with sudden vision loss in the right eye. Examination with optical coherence tomography (OCT) imaging revealed submacular hemorrhage. The patient underwent vitrectomy with subretinal tissue plasminogen activator (tPA) with no intraoperative complications. Dilated fundus examination and OCT imaging revealed a FTMH at postop week 1. Possible causes for MH development include the submacular hemorrhage itself and subretinal administration of the tPA infusion. [Ophthalmic Surg Lasers Imaging Retina. 2019;50:e257-e259.].

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Choroidal Neovascularization / complications*
  • Endotamponade
  • Fibrinolytic Agents / therapeutic use*
  • Fluorescein Angiography
  • Humans
  • Injections, Intraocular / adverse effects*
  • Male
  • Retinal Hemorrhage / diagnostic imaging
  • Retinal Hemorrhage / drug therapy*
  • Retinal Hemorrhage / etiology
  • Retinal Perforations / diagnostic imaging
  • Retinal Perforations / etiology*
  • Tissue Plasminogen Activator / therapeutic use*
  • Tomography, Optical Coherence
  • Visual Acuity
  • Vitrectomy
  • Wet Macular Degeneration / complications*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator